Frontiers in public health
Targeting pro-dopaminergic agonism to attenuate depression in patients displaying genetic/epigenetic predisposition to hypodopaminergia.
Kai-Uwe Lewandrowski, Kenneth Blum, Alexander P L Lewandrowski, Panayotis K Thanos, Albert Pinhasov, Alireza Sharafshah, David Baron, Mark S Gold, Catherine A Dennen, Igor Elman, Aballa Bowirrat, Edward J Modestino, Foojan Zeine, Nicole Jafari, Keerthy Sunder
Published: 202510.3389/fpubh.2025.1594872
No abstract available for this study.